Crewe Advisors »

Seelos Therapeutics shares owned by Crewe Advisors

Quarter-by-quarter ownership of Seelos Therapeutics shares owned by Crewe Advisors from 13F filings

Historical chart of Crewe Advisors investment in Seelos Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Seelos Therapeutics held by Crewe Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Seelos Therapeutics by Crewe Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $26 7 3.86

More positions owned by Crewe Advisors

Ensign (ENSG)
Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p Mcp Etf (IJH)
Berkshire Hathaway Inc Del Cl A (BRK.A)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Vanguard World Esg Us Stk Etf (ESGV)
Dbx Etf Tr Xtrack Msci Eafe (DBEF)
Spdr S&p Midcap 400 Etf Tr Utser1 S&pdcrp (MDY)
Pennant Group (PNTG)
Vanguard Index Fds Small Cp Etf (VB)
Ishares Tr Russell 2000 Etf (IWM)
Ishares Tr National Mun Etf (MUB)
Ishares Tr Core Msci Eafe (IEFA)
Vanguard World Inf Tech Etf (VGT)

View all positions for Crewe Advisors

Top funds holding Seelos Therapeutics

Modera Wealth Management
BlackRock
Carmichael Hill & Associates
Bank of America Corporation
Jpmorgan Chase & Co
Group One Trading
Crewe Advisors
Wells Fargo & Company
Newbridge Financial Services Group

View all funds holding Seelos Therapeutics